Hematopoietic cell transplantation for lymphomas.

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Lymphoma heterogeneity necessitates diverse treatment strategies.
• Hematopoietic cell transplantation (HCT) is a key therapeutic modality.
• Optimal HCT approaches, including timing and patient selection, are continually refined.

Purpose of the Study:

• To synthesize current medical literature on HCT for common lymphomas.
• To outline indications for autologous and allogeneic transplantation.
• To provide a concise overview for clinicians and researchers.

Main Methods:

• Comprehensive review of existing medical literature.
• Focus on common lymphoma subtypes.
• Synthesis of data on transplantation outcomes and indications.

Main Results:

• Outcomes of autologous and allogeneic HCT discussed for specific lymphomas.
• Includes diffuse large B-cell lymphoma, follicular lymphoma, HIV-associated lymphomas, mantle cell lymphoma, T-cell lymphoma, and Hodgkin lymphoma.
• Highlights differences in transplantation indications and timing across histologies.

Conclusions:

• Transplantation indications and timing vary significantly by lymphoma histology.
• Ongoing clinical trials continue to support HCT's role in lymphoma treatment.
• Both autologous and allogeneic HCT remain vital for managing lymphoma.